Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Usability of Vibro-tactile Stimulation to Treat Spasmodic Dysphonia

NCT: NCT06111027 · COMPLETED

NCT IDNCT06111027
StatusCOMPLETED
Start Date2023-11-21
Completion2024-10-31
SponsorUniversity of Minnesota (OTHER)
First posted
Last updated

Brief Summary

The general aim of the study was to provide evidence for the usability and feasibility of applying vibro-tactile stimulation (VTS) at home as a non-invasive form of neuromodulation to improve speech in people with spasmodic dysphonia (laryngeal dystonia). This work addresses a clinical need to develop alternative or auxiliary treatments for a rare voice disorder with limited treatment options.

Frequently Asked Questions

What is Usability of Vibro-tactile Stimulation to Treat Spasmodic Dysphonia?

Usability of Vibro-tactile Stimulation to Treat Spasmodic Dysphonia is a clinical trial registered under NCT06111027. Current status: COMPLETED.

What is the status of NCT06111027?

The current status of NCT06111027 (Usability of Vibro-tactile Stimulation to Treat Spasmodic Dysphonia) is: COMPLETED.

When did Usability of Vibro-tactile Stimulation to Treat Spasmodic Dysphonia start?

Usability of Vibro-tactile Stimulation to Treat Spasmodic Dysphonia started on 2023-11-21.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.